Pages that link to "Proto-oncogene tyrosine-protein kinase Src"
Showing 50 items.
- Janus kinase (links | edit)
- Oncogene (links | edit)
- P53 (links | edit)
- Retroposon (links | edit)
- Tumor suppressor gene (links | edit)
- Tyrosine kinase (links | edit)
- Ras GTPase (links | edit)
- Metabotropic receptor (links | edit)
- BRCA1 (links | edit)
- Insulin receptor (links | edit)
- Bcl-2 (links | edit)
- Platelet-derived growth factor (links | edit)
- Src (gene) (redirect page) (links | edit)
- Chemotherapy (links | edit)
- G protein-coupled receptor (links | edit)
- Janus kinase (links | edit)
- Oncogene (links | edit)
- Peter Duesberg (links | edit)
- Proteasome (links | edit)
- Retrovirus (links | edit)
- Tyrosine kinase (links | edit)
- Reelin (links | edit)
- Sodium–potassium pump (links | edit)
- SRC (links | edit)
- NMDA receptor (links | edit)
- Monoamine transporter (links | edit)
- Sirolimus (links | edit)
- Everolimus (links | edit)
- Imatinib (links | edit)
- Insulin receptor (links | edit)
- Trastuzumab (links | edit)
- Wiskott–Aldrich syndrome protein (links | edit)
- ATC code L (links | edit)
- ATC code L01 (links | edit)
- Gefitinib (links | edit)
- Rituximab (links | edit)
- J. Michael Bishop (links | edit)
- Bevacizumab (links | edit)
- Estrogen receptor (links | edit)
- Cetuximab (links | edit)
- Biochemical cascade (links | edit)
- Epidermal growth factor receptor (links | edit)
- Netrin (links | edit)
- Androgen receptor (links | edit)
- Erlotinib (links | edit)
- SH2 domain (links | edit)
- Ibritumomab tiuxetan (links | edit)
- Hepatocyte growth factor receptor (links | edit)
- Alemtuzumab (links | edit)
- Waldenström macroglobulinemia (links | edit)
- Gemtuzumab ozogamicin (links | edit)
- Targeted therapy (links | edit)
- CD44 (links | edit)
- Sorafenib (links | edit)
- Sunitinib (links | edit)
- Glyceraldehyde 3-phosphate dehydrogenase (links | edit)
- Rous sarcoma virus (links | edit)
- Lapatinib (links | edit)
- Reeler (links | edit)
- Estrogen receptor alpha (links | edit)
- C-Raf (links | edit)
- Receptor tyrosine kinase (links | edit)
- GRB2 (links | edit)
- Nilotinib (links | edit)
- Dasatinib (links | edit)
- RANKL (links | edit)
- Denileukin diftitox (links | edit)
- Tositumomab (links | edit)
- Netrin receptor DCC (links | edit)
- Dystroglycan (links | edit)
- Cortactin (links | edit)
- Monoclonal antibody therapy (links | edit)
- Panitumumab (links | edit)
- Interleukin 24 (links | edit)
- Vandetanib (links | edit)
- Edrecolomab (links | edit)
- CCL18 (links | edit)
- Pertuzumab (links | edit)
- Catumaxomab (links | edit)
- Ipilimumab (links | edit)
- Tremelimumab (links | edit)
- G protein-coupled receptor kinase 2 (links | edit)
- KIT (gene) (links | edit)
- Adapter molecule crk (links | edit)
- Inotuzumab ozogamicin (links | edit)
- Ofatumumab (links | edit)
- Semaxanib (links | edit)
- Protein kinase inhibitor (links | edit)
- V-Src (links | edit)
- Cediranib (links | edit)
- STAT3 (links | edit)
- STAT1 (links | edit)
- Low-density lipoprotein receptor-related protein 8 (links | edit)
- RET proto-oncogene (links | edit)
- Protein kinase C zeta type (links | edit)
- Alpha-enolase (links | edit)
- Honokiol (links | edit)
- Pazopanib (links | edit)
- Temsirolimus (links | edit)
- FYN (links | edit)
- Estrogen receptor beta (links | edit)
- PRKCD (links | edit)
- PTK2 (links | edit)
- HNF1A (links | edit)
- Mucin short variant S1 (links | edit)
- PLCG1 (links | edit)
- Retinoic acid receptor alpha (links | edit)
- RAS p21 protein activator 1 (links | edit)
- Cadherin-2 (links | edit)
- KHDRBS1 (links | edit)
- PLD2 (links | edit)
- PSMA3 (links | edit)
- PTPN1 (links | edit)
- PTK2B (links | edit)
- PSMA4 (links | edit)
- PSMB1 (links | edit)
- DAB2 (links | edit)
- CDC37 (links | edit)
- PSMB4 (links | edit)
- PSMD10 (links | edit)
- PSMD13 (links | edit)
- ACP1 (links | edit)
- PSMB10 (links | edit)
- PSMB2 (links | edit)
- PSMD12 (links | edit)
- PSMB3 (links | edit)
- PSMD5 (links | edit)
- Oncogenic retroviridae protein (links | edit)
- Serum response factor (links | edit)
- Receptor for activated C kinase 1 (links | edit)
- EPH receptor B2 (links | edit)
- GRIN2A (links | edit)
- Beta-3 adrenergic receptor (links | edit)
- Protein kinase domain (links | edit)
- Axitinib (links | edit)
- PSMB8 (links | edit)
- PSMD4 (links | edit)
- IQGAP1 (links | edit)
- PSMB9 (links | edit)
- PSMA6 (links | edit)
- Proteasome (prosome, macropain) subunit, alpha 1 (links | edit)
- PSMA7 (links | edit)
- PSMB5 (links | edit)
- PSMC1 (links | edit)
- PSMA2 (links | edit)
- PSMD7 (links | edit)
- NEDD9 (links | edit)
- PSMA5 (links | edit)
- PSMB7 (links | edit)
- PSMD1 (links | edit)
- PSMD2 (links | edit)
- PSMD11 (links | edit)
- PSMD8 (links | edit)
- PSMB6 (links | edit)
- PSMD9 (links | edit)
- PSMD3 (links | edit)
- PSMD6 (links | edit)
- NCOA6 (links | edit)
- SHB (gene) (links | edit)
- EPS8 (links | edit)
- ARHGDIB (links | edit)
- PDE6G (links | edit)
- Protein phosphorylation (links | edit)
- Kinesin-associated protein 3 (links | edit)
- DDEF1 (links | edit)
- RICS (gene) (links | edit)
- Dedicator of cytokinesis protein 4 (links | edit)
- PSMD14 (links | edit)
- Ridaforolimus (links | edit)
- Lestaurtinib (links | edit)
- Bosutinib (links | edit)
- Aflibercept (links | edit)
- Epileptogenesis (links | edit)
- Elotuzumab (links | edit)
- Blinatumomab (links | edit)
- Afatinib (links | edit)
- Ramucirumab (links | edit)
- Obinutuzumab (links | edit)
- Non-receptor tyrosine kinase (links | edit)
- Neratinib (links | edit)
- Necitumumab (links | edit)
- Oportuzumab monatox (links | edit)
- Toceranib (links | edit)
- Lenvatinib (links | edit)
- Short linear motif (links | edit)
- Regorafenib (links | edit)
- Apatinib (links | edit)
- Brentuximab vedotin (links | edit)
- CDK inhibitor (links | edit)
- SU6656 (links | edit)
- Olaratumab (links | edit)
- Src homology domain (links | edit)
- Mubritinib (links | edit)
- BOSC23 (links | edit)
- Erbulozole (links | edit)
- Tyrosine kinase inhibitor (links | edit)
- Crizotinib (links | edit)
- Tivozanib (links | edit)
- Vemurafenib (links | edit)
- Src family kinase (links | edit)
- Quizartinib (links | edit)
- Trastuzumab emtansine (links | edit)
- Midostaurin (links | edit)
- Ruxolitinib (links | edit)
- Nintedanib (links | edit)
- Cabozantinib (links | edit)
- Ponatinib (links | edit)
- Cyclase-associated protein family (links | edit)
- Vismodegib (links | edit)
- Selumetinib (links | edit)
- Brigatinib (links | edit)
- Chemotherapy-induced nausea and vomiting (links | edit)
- Mogamulizumab (links | edit)
- Moxetumomab pasudotox (links | edit)
- Daratumumab (links | edit)
- Prohibitin-targeting peptide 1 (links | edit)
- Fedratinib (links | edit)
- Momelotinib (links | edit)
- Ibrutinib (links | edit)
- Nivolumab (links | edit)
- Masitinib (links | edit)
- YTH protein domain (links | edit)
- Murine polyomavirus (links | edit)
- CBLL1 (links | edit)
- Tyrosine phosphorylation (links | edit)
- Role of cell adhesions in neural development (links | edit)
- Trametinib (links | edit)
- Dabrafenib (links | edit)
- Margetuximab (links | edit)
- Encorafenib (links | edit)
- Pembrolizumab (links | edit)
- Palbociclib (links | edit)
- Cobimetinib (links | edit)
- Pacritinib (links | edit)
- Radotinib (links | edit)
- Icotinib (links | edit)
- Zolbetuximab (links | edit)
- Sonidegib (links | edit)
- Dacomitinib (links | edit)
- Ceritinib (links | edit)
- CASS4 (links | edit)
- Embryonal fyn-associated substrate (links | edit)
- Filgotinib (links | edit)
- Dinutuximab (links | edit)
- Binimetinib (links | edit)
- Enfortumab vedotin (links | edit)
- Polatuzumab vedotin (links | edit)
- Durvalumab (links | edit)
- Isatuximab (links | edit)
- Atezolizumab (links | edit)
- Sacituzumab govitecan (links | edit)
- Osimertinib (links | edit)
- List of antineoplastic agents (links | edit)
- Avelumab (links | edit)
- Venetoclax (links | edit)
- Acalabrutinib (links | edit)
- Alectinib (links | edit)
- Pexidartinib (links | edit)
- Cardioprotection (links | edit)
- Mirvetuximab soravtansine (links | edit)
- Rociletinib (links | edit)
- Entrectinib (links | edit)
- Bermekimab (links | edit)
- Capmatinib (links | edit)
- Tesevatinib (links | edit)
- Tislelizumab (links | edit)
- Olmutinib (links | edit)
- Lorlatinib (links | edit)
- Glasdegib (links | edit)
- Larotrectinib (links | edit)
- Tucatinib (links | edit)
- Erdafitinib (links | edit)
- Sitravatinib (links | edit)
- Middle tumor antigen (links | edit)
- Silmitasertib (links | edit)
- Gilteritinib (links | edit)
- Loncastuximab tesirine (links | edit)
- Cemiplimab (links | edit)
- Ivosidenib (links | edit)
- Tepotinib (links | edit)
- Dostarlimab (links | edit)
- Zanubrutinib (links | edit)
- Sotorasib (links | edit)
- Abrocitinib (links | edit)
- Trastuzumab deruxtecan (links | edit)
- Avapritinib (links | edit)
- Pemigatinib (links | edit)
- Selpercatinib (links | edit)
- Ripretinib (links | edit)
- Pertuzumab/trastuzumab/hyaluronidase (links | edit)
- Tafasitamab (links | edit)
- Belantamab mafodotin (links | edit)
- Trastuzumab/hyaluronidase (links | edit)
- Pralsetinib (links | edit)
- Naxitamab (links | edit)
- Mobocertinib (links | edit)
- Adagrasib (links | edit)
- Amivantamab (links | edit)
- Infigratinib (links | edit)
- Tisotumab vedotin (links | edit)
- Asciminib (links | edit)
- Tebentafusp (links | edit)
- Nivolumab/relatlimab (links | edit)
- Mosunetuzumab (links | edit)
- Teclistamab (links | edit)
- Futibatinib (links | edit)
- Pirtobrutinib (links | edit)
- Talquetamab (links | edit)
- Inavolisib (links | edit)
- Retifanlimab (links | edit)
- Glofitamab (links | edit)
- Epcoritamab (links | edit)
- Elranatamab (links | edit)
- Toripalimab (links | edit)
- Fruquintinib (links | edit)
- Capivasertib (links | edit)
- Repotrectinib (links | edit)
- Odronextamab (links | edit)
- Tarlatamab (links | edit)
- Parsaclisib (links | edit)
- Aumolertinib (links | edit)
- Surufatinib (links | edit)
- Orelabrutinib (links | edit)
- Tovorafenib (links | edit)
- Sugemalimab (links | edit)
- Axatilimab (links | edit)
- Lazertinib (links | edit)
- Atezolizumab/hyaluronidase (links | edit)
- Serplulimab (links | edit)
- Revumenib (links | edit)
- Zanidatamab (links | edit)
- Zenocutuzumab (links | edit)
- Talk:Src (gene) (links | edit)
- Talk:Rous sarcoma virus (links | edit)
- Talk:Proto-oncogene tyrosine-protein kinase Src (links | edit)
- User:ProteinBoxBot/PBB Log Wiki Test Run noUpload1 (links | edit)
- User:ProteinBoxBot/PBB Log Wiki Live Run (links | edit)
- User:ProteinBoxBot/PBB Live run-Dry (links | edit)
- User:ProteinBoxBot/PBB Log Wiki Live Run 2 (links | edit)
- User:ProteinBoxBot/PBB Log Wiki Live Run3 Char Fix (links | edit)
- User:Andrew Su/Merge candidates (links | edit)
- User:ProteinBoxBot/Protein Directory links (links | edit)
- User:Mad Price Ball/Genetics counts (links | edit)
- User:Andrew Su/Interactions (links | edit)
- User:Joachimherz/Books/LDLR family + Reelin (links | edit)
- User:West.andrew.g/Dead links/Archive 488 (links | edit)
- User:KielCrow/sandbox (links | edit)
- User:Fvasconcellos/T-DM1 (links | edit)
- User:Charliemassie/sandbox (links | edit)
- User:Nascent 518/sandbox (links | edit)
- User:Immcarle59/sandbox (links | edit)
- User:Immcarle85/sandbox (links | edit)
- User:Y-S.Ko/Wikipedia course/Medical/Oncology (links | edit)
- User:Y-S.Ko/Wikipedia course/Pharmacology/L-V (links | edit)
- User:Noxoug1/Tovorafenib (links | edit)
- User:Noxoug1/template-product (links | edit)
- User:Noxoug1/Lazertinib-template (links | edit)
- User talk:Nzohoury (links | edit)
- User talk:Joachimherz/Books/LDLR family + Reelin (links | edit)
- User talk:Linkawai (links | edit)
- Wikipedia:Reference desk/Archives/Science/2010 March 5 (links | edit)
- Wikipedia:WikiProject Spam/LinkReports/cmkb.cellmigration.org (links | edit)
- Wikipedia:WikiProject Spam/LinkReports/cellmigration.org (links | edit)
- Wikipedia:WikiProject Spam/LinkReports/pcz-consulting.com (links | edit)
- Wikipedia:Village pump (technical)/Archive 109 (links | edit)
- Wikipedia talk:WikiProject Molecular Biology/Molecular and Cell Biology/Archive 4 (links | edit)
- Template:Targeted cancer therapeutic agents (links | edit)
- Template:ImportProtein/Src (gene) (links | edit)
- Module:ImportProtein (links | edit)
- Module:ImportProtein/doc (links | edit)
- Module:ImportProtein/sandbox (links | edit)
- Module talk:ImportProtein (links | edit)
- BRCA2 (links | edit)
- SDHD (links | edit)
- L1 (protein) (links | edit)
- Tau protein (links | edit)
- Protein kinase B (links | edit)
- Epidermal growth factor receptor (links | edit)
- P73 (links | edit)
- Soluble fms-like tyrosine kinase-1 (links | edit)
- ABL (gene) (links | edit)
- Myristoylation (links | edit)
- Hepatocyte growth factor receptor (links | edit)
- HER2 (links | edit)
- Stathmin (links | edit)
- PTEN (gene) (links | edit)
- Adenomatous polyposis coli (links | edit)
- HRAS (links | edit)
- Tyrosin-protein kinase Lck (links | edit)
- Mdm2 (links | edit)
- MuSK protein (links | edit)
- Merlin (protein) (links | edit)
- SDHB (links | edit)
- Myosin light-chain kinase (links | edit)
- Francis Peyton Rous (links | edit)
- ROR2 (links | edit)
- Tropomyosin receptor kinase A (links | edit)
- Tropomyosin receptor kinase B (links | edit)
- Tropomyosin receptor kinase C (links | edit)
- Insulin-like growth factor 1 receptor (links | edit)
- P21 (links | edit)
- Catenin beta-1 (links | edit)
- C-Raf (links | edit)
- Receptor tyrosine kinase (links | edit)
- Ephrin receptor (links | edit)
- Mothers against decapentaplegic homolog 2 (links | edit)
- Mothers against decapentaplegic homolog 4 (links | edit)
- Platelet-derived growth factor receptor (links | edit)
- Fibroblast growth factor receptor (links | edit)